# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0000950170-23-032444
Filing Date
2023-07-11
Accepted
2023-07-11 07:06:42
Documents
46
Period of Report
2023-07-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | eypt-20230711.htm iXBRL | 8-K | 54018
2 | EX-99.1 | eypt-ex99_1.htm | EX-99.1 | 25512
3 | GRAPHIC | eypt-ex99_1s1.jpg | GRAPHIC | 206608
4 | GRAPHIC | eypt-ex99_1s2.jpg | GRAPHIC | 988943
5 | GRAPHIC | eypt-ex99_1s3.jpg | GRAPHIC | 445092
6 | GRAPHIC | eypt-ex99_1s4.jpg | GRAPHIC | 360370
7 | GRAPHIC | eypt-ex99_1s5.jpg | GRAPHIC | 329806
8 | GRAPHIC | eypt-ex99_1s6.jpg | GRAPHIC | 388375
9 | GRAPHIC | eypt-ex99_1s7.jpg | GRAPHIC | 412364
10 | GRAPHIC | eypt-ex99_1s8.jpg | GRAPHIC | 359753
11 | GRAPHIC | eypt-ex99_1s9.jpg | GRAPHIC | 160897
12 | GRAPHIC | eypt-ex99_1s10.jpg | GRAPHIC | 360867
13 | GRAPHIC | eypt-ex99_1s11.jpg | GRAPHIC | 466053
14 | GRAPHIC | eypt-ex99_1s12.jpg | GRAPHIC | 372616
15 | GRAPHIC | eypt-ex99_1s13.jpg | GRAPHIC | 466828
16 | GRAPHIC | eypt-ex99_1s14.jpg | GRAPHIC | 511315
17 | GRAPHIC | eypt-ex99_1s15.jpg | GRAPHIC | 346373
18 | GRAPHIC | eypt-ex99_1s16.jpg | GRAPHIC | 222180
19 | GRAPHIC | eypt-ex99_1s17.jpg | GRAPHIC | 336414
20 | GRAPHIC | eypt-ex99_1s18.jpg | GRAPHIC | 365465
21 | GRAPHIC | eypt-ex99_1s19.jpg | GRAPHIC | 383416
22 | GRAPHIC | eypt-ex99_1s20.jpg | GRAPHIC | 401488
23 | GRAPHIC | eypt-ex99_1s21.jpg | GRAPHIC | 341831
24 | GRAPHIC | eypt-ex99_1s22.jpg | GRAPHIC | 154607
25 | GRAPHIC | eypt-ex99_1s23.jpg | GRAPHIC | 415680
26 | GRAPHIC | eypt-ex99_1s24.jpg | GRAPHIC | 379964
27 | GRAPHIC | eypt-ex99_1s25.jpg | GRAPHIC | 161806
28 | GRAPHIC | eypt-ex99_1s26.jpg | GRAPHIC | 423994
29 | GRAPHIC | eypt-ex99_1s27.jpg | GRAPHIC | 365433
30 | GRAPHIC | eypt-ex99_1s28.jpg | GRAPHIC | 194272
31 | GRAPHIC | eypt-ex99_1s29.jpg | GRAPHIC | 390128
32 | GRAPHIC | eypt-ex99_1s30.jpg | GRAPHIC | 407807
33 | GRAPHIC | eypt-ex99_1s31.jpg | GRAPHIC | 270878
34 | GRAPHIC | eypt-ex99_1s32.jpg | GRAPHIC | 356393
35 | GRAPHIC | eypt-ex99_1s33.jpg | GRAPHIC | 205138
| Complete submission text file | 0000950170-23-032444.txt |  | 16661594

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
36 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | eypt-20230711_lab.xml | EX-101.LAB | 12806
37 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | eypt-20230711_pre.xml | EX-101.PRE | 9457
38 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | eypt-20230711.xsd | EX-101.SCH | 2475
40 | EXTRACTED XBRL INSTANCE DOCUMENT | eypt-20230711_htm.xml | XML | 4523

Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51122 | Film No.: 231081195
SIC: 3826 Laboratory Analytical Instruments